ACC 2024 Hybrid Group Meetings

Sunday,  April 7,  Guidepoint Insights will be hosting a series of group meetings featuring KOLs who will dive deeper into ACC 2024 updates.

    Sunday, April 7th
    8:00 AM ET - Ahmad Masri
    • Hypertrophic Cardiomyopathy, Cytokinetics (SEQUIOA Data) | Director of Hypertrophic Cardiomyopathy and Amyloidosis Centers, Oregon Health & Science University
    9:00 AM ET - John Ryan
    • Hypertension, Alnylam/Roche Vutrisiran KARDIA-2 Data | Associate Professor, Chief of General Cardiology, The University of Utah
    10:00 AM ET - Carlos Garcia Santos-Gallego
    • Pfizer, Alnylam, BridgeBio, Transthyretin Cardiomyopathy | Cardiologist, The Mount Sinai Hospital
    12:00 PM ET - Ronald H Wharton
    • Hypertrophic Cardiomyopathy, Cytokinetics (SEQUIOA Data) | Cardiologist, North Shore University Hospital
    1:00 PM ET - Martin Maron
    • Hypertrophic Cardiomyopathy, Cytokinetics (SEQUIOA Data) | Medical Director, HCM Center, Lahey Hospital & Medical Center
    2:00 PM ET - James Underberg
    • Lipidology, New Amsterdam, Novartis (inclisiran), Esperion | President, Foundation of the National Lipid Association

    *ACC Group Meetings will be 50 minutes long and available only to attendees. Group meetings are not recorded and transcripts will not be available following the event.

    This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.